A multi-billion-dollar subsidiary of a Fortune 500 company and global supplier of medical products experienced serious brand-confidence issues when patient fatalities resulted from the use of what appeared to be their product. An internal investigation revealed the tainted product was actually part of a professional and widespread counterfeiting operation.Learn more about how they tackled this challenge.
COMPLETE THIS FORM TO ACCESS YOUR CONTENT 